Fort Washington Investment Advisors Inc. OH Acquires 56,023 Shares of The Ensign Group, Inc. $ENSG

Fort Washington Investment Advisors Inc. OH increased its holdings in shares of The Ensign Group, Inc. (NASDAQ:ENSG) by 40.2% in the third quarter, Holdings Channel.com reports. The firm owned 195,540 shares of the company’s stock after purchasing an additional 56,023 shares during the quarter. Fort Washington Investment Advisors Inc. OH’s holdings in The Ensign Group were worth $33,633,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of ENSG. Transamerica Financial Advisors LLC bought a new position in The Ensign Group in the second quarter valued at approximately $26,000. Monetary Solutions Ltd acquired a new position in shares of The Ensign Group in the fourth quarter valued at approximately $30,000. Bayban acquired a new position in shares of The Ensign Group in the fourth quarter valued at approximately $31,000. Caitlin John LLC acquired a new position in shares of The Ensign Group in the second quarter valued at approximately $31,000. Finally, Cedar Mountain Advisors LLC bought a new stake in shares of The Ensign Group during the first quarter worth $32,000. 96.12% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on ENSG shares. Wall Street Zen upgraded shares of The Ensign Group from a “hold” rating to a “buy” rating in a report on Saturday, October 3rd. Truist Financial upped their target price on shares of The Ensign Group from $202.00 to $207.00 and gave the stock a “hold” rating in a research note on Thursday, July 30th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $228.00 target price on shares of The Ensign Group in a research note on Tuesday, July 28th. Finally, Weiss Ratings upgraded The Ensign Group from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. Four equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $216.25.

Key The Ensign Group News

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: No new deterioration in Ensign’s operating results was reported in these articles. The company’s most recently provided financial backdrop remains supportive, including quarterly earnings that exceeded analyst expectations and double-digit year-over-year revenue growth.
• Neutral Sentiment: Multiple law firms—including Rosen, Kaplan Fox, Robbins Geller, and others—are seeking investors who may serve as lead plaintiff. Investors covered by the alleged class period, February 10, 2022 through June 18, 2026, generally have until December 7, 2026 to apply. Rosen class action announcement
• Negative Sentiment: The repeated notices confirm that a securities class action is pending against The Ensign Group and certain officers on behalf of investors who allege losses. The litigation could result in legal expenses, settlement costs, management distraction, and continued volatility; however, the articles provide allegations rather than a judgment or quantified financial liability. Bronstein Gewirtz Grossman lawsuit announcement

The Ensign Group Price Performance

NASDAQ ENSG opened at $178.11 on Friday. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.06. The Ensign Group, Inc. has a 12-month low of $141.58 and a 12-month high of $218.00. The company has a market capitalization of $10.38 billion, a PE ratio of 27.92, a price-to-earnings-growth ratio of 1.67 and a beta of 0.66. The firm’s 50 day moving average is $175.55 and its 200-day moving average is $175.58.

The Ensign Group (NASDAQ:ENSG) last announced its quarterly earnings data on Monday, July 27th. The company reported $1.92 EPS for the quarter, topping analysts’ consensus estimates of $1.80 by $0.12. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The business had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.44 billion. During the same quarter in the previous year, the firm posted $1.59 earnings per share. The firm’s revenue for the quarter was up 16.7% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Equities research analysts anticipate that The Ensign Group, Inc. will post 7.04 earnings per share for the current fiscal year.

The Ensign Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Saturday, October 31st. Shareholders of record on Wednesday, September 30th will be paid a $0.0650 dividend. This represents a $0.26 annualized dividend and a yield of 0.1%. The ex-dividend date is Wednesday, September 30th. The Ensign Group’s payout ratio is presently 4.08%.

Insider Transactions at The Ensign Group

In other The Ensign Group news, Director John Agwunobi sold 392 shares of the business’s stock in a transaction dated Monday, July 20th. The shares were sold at an average price of $171.06, for a total transaction of $67,055.52. Following the sale, the director directly owned 9,503 shares of the company’s stock, valued at $1,625,583.18. The trade was a 3.96% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 4.00% of the company’s stock.

The Ensign Group Profile

The Ensign Group, Inc (NASDAQ: ENSG) is a healthcare services company that operates through a network of skilled nursing, rehabilitation and senior living facilities. Its centers provide post-acute care, including nursing services, physical, occupational and speech therapy, short-term rehabilitation, and long-term residential care for older adults and patients recovering from illness, injury or surgery.

The company also provides home health and hospice services, as well as a range of ancillary services supporting post-acute care.